Total Funding
22
Total FundingSeries B raised
Growth Score
pts
Heat Score
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
149233
OncoImmune is a clinical-stage biopharmaceutical company that develops solutions for the treatment of cancer.
- Pan Zheng: Co-Founder, Senior Vice President and Chief Medical Officer
- Yang Liu: Co-Founder, President and Chief Scientific OfficerPast Role: Piezonix LLC, CEO & Co-Founder
About the Company
OncoImmune is a clinical-stage biopharmaceutical company that engages in the discovery and development of biopharmaceuticals for the treatment of cancer and autoimmune disease. It has completed a Phase II clinical trial of CD24Fc for the prophylactic treatment of acute Graft versus Host Disease for leukemia patients undergoing hematopoietic stem
cell transplantation and is poised to launch a pivotal trial for the indication.
Oncolmmune was founded in 2000 and is based in Rockville, Maryland.
